NATIONAL INSTITUTES OF HEALTH RESEARCH FUNDING PER DISEASE

(
Reproduction of NIH Table. It should be noted that the 2006 estimates have been adjusted lower by the NIH. Since funding has been reduced for most illnesses in 2007, this 2006 change gives the impression of a lesser reduction in funding than what has actually occurred.)

Research/Disease Areas
(Dollars in millions
and rounded)
FY 2003
Actual
FY 2004
Actual
FY 2005
Actual
FY 2006
Estimate
FY 2007
Estimate
 
Acute Respiratory Distress Syndrome
$77
$72
$72
$72
$72
Agent Orange & Dioxin
18
20
20
20
19
Aging
2,211
2,343
2,415
2,400
2,379
Alcoholism
493
503
512
509
505
Allergic Rhinitis (Hay Fever)
2
2
3
3
3
ALS
40
47
42
42
41
Alzheimer's Disease
658
633
656
652
645
American Indians/
Alaska Natives
108
134
140
140
139
Anorexia
10
12
14
14
14
Anthrax
219
249
183
180
185
Antimicrobial Resistance
181
203
217
218
216
Aphasia
N/A
5
3
3
3
Arctic
33
25
22
22
22
Arthritis
380
374
368
364
361
Assistive Technology
126
131
138
138
137
Asthma
248
272
289
293
295
Ataxia Telangiectasia
10
9
10
10
10
Atherosclerosis
318
326
322
323
325
Attention Deficit Disorder (ADD)
103
104
107
106
105
Autism
93
100
102
102
101
Autoimmune Disease
591
584
589
586
584
Basic Behavioral and Social Science
938
1,052
1,065
1,058
1,050
Batten Disease
8
8
9
9
8
Behavioral and Social Science
2,684
2,932
3,044
3,026
3,005
Biodefense
1,554
1,629
1,696
1,781
1,891
Bioengineering
1,006
1,216
1,318
1,291
1,296
Biotechnology
9,893
10,685
10,889
10,888
10,834
Brain Cancer
164
187
157
156
155
Brain Disorders
4,740
4,821
4,784
4,757
4,720
Breast Cancer
693
708
700
697
690
Burden of Illness
424
429
433
434
434
Cancer
5,432
5,547
5,639
5,590
5,529
Cardiovascular
2,286
2,360
2,333
2,341
2,347
Cerebral Palsy
18
22
23
23
22
Cervical Cancer
92
94
96
96
94
Childhood Abuse and Neglect Research
N/A
N/A
40
40
40
Childhood Leukemia
70
62
60
60
59
Chronic Fatigue Syndrome
6
5
5
7
7
Chronic Liver Disease and Cirrhosis
348
362
410
408
406
Chronic Obstructive Pulmonary Disease
54
55
63
63
63
Climate Change
N/A
63
57
57
57
Clinical Research
8,028
8,495
8,719
8,724
8,704
Clinical Trials
2,723
2,877
2,863
2,843
2,830
Colo-Rectal Cancer
295
297
284
282
280
Complementary and Alternative Medicine
296
309
306
303
301
Conditions affecting Unborn children
111
113
108
107
106
Contraception/
Reproduction
330
355
340
341
340
Cooley's Anemia
55
47
42
42
42
Cost Effectiveness Research
N/A
126
134
134
133
Crohn's Disease
50
53
59
59
59
Cystic Fibrosis
117
128
89
89
89
Dental/Oral Disease
401
410
415
410
406
Depression
288
302
329
329
328
Diabetes
910
996
1,055
1,055
1,053
Diagnostic Radiology
717
750
788
784
778
Diethylstilbestrol (DES)
8
8
9
9
8
Digestive Diseases
1,137
1,237
1,237
1,232
1,223
Digestive Diseases - (Gallbladder)
7
7
7
7
7
Digestive Diseases - (Peptic Ulcer)
17
18
18
18
18
Down Syndrome
23
19
15
16
16
Drug Abuse (NIDA only)
966
992
1,006
1,000
995
Duchenne/Becker Muscular Dystrophy
16
18
17
17
17
Dystonia
13
15
19
19
19
Emerging Infectious Diseases
1,362
1,807
1,872
1,882
1,814
Emphysema
18
17
21
21
21
Endometriosis
14
9
10
10
9
Epilepsy
94
102
105
106
103
Estrogen
210
204
183
182
181
Eye Disease and Disorders of Vision
688
693
715
710
702
Fasiocapulohumeral Muscular Dystrophy
N/A
2
2
2
2
Fetal Alcohol Syndrome
29
25
28
28
27
Fibroid Tumors (Uterine)
15
13
15
15
14
Fibromyalgia
10
9
10
10
10
Food Safety
208
294
329
331
333
Fragile X Syndrome
19
20
22
22
22
Frontotemporal Dementia (FTD)
N/A
21
29
29
29
Gene Therapy
410
391
355
354
353
Gene Therapy Clinical Trials
39
37
31
31
31
Genetic Testing
426
401
422
422
420
Genetics
4,236
4,535
4,840
4,822
4,780
Global Warming Climate Change
N/A
N/A
24
24
24
Health Disparities
2,430
2,590
2,699
2,689
2,675
Health Effects of Climate Change
158
165
159
158
156
Health Services
873
887
940
938
934
Heart Disease
2,013
2,110
2,087
2,096
2,103
Heart Disease: Coronary Heart Disease
429
416
397
399
401
Hematology
1,120
1,131
1,122
1,124
1,120
Hepatitis
N/A
162
179
180
180
Hepatitis-A
N/A
3
5
5
5
Hepatitis-B
N/A
32
39
39
39
Hepatitis-C
112
116
121
122
122
           
HIV/AIDS 1/
2,718
2,850
2,921
2,904
2,888
------Minority AIDS     699 not avail.2 not avail.2
------Pediatric AIDS     283 274 272
------AIDS Vaccine     515 not avail.2 621
           
Hodgkin's Disease
17
17
18
18
17
Homelessness
24
24
24
24
24
Homicide and Legal Interventions
13
15
12
12
12
HPV and/or Cervical Cancer Vaccines
15
14
16
16
16
Human Fetal Tissue
26
23
24
24
24
Human Genome
1,100
1,118
1,084
1,078
1,070
Huntington's Disease
45
49
48
48
47
Hyperbaric Oxygen
3
4
2
2
2
Hypertension
347
378
371
372
372
Immunization
1,059
1,585
1,438
1,550
1,515
Infant Mortality/ (LBW)
523
513
504
506
506
Infectious Diseases
2,441
3,055
3,188
3,165
3,137
Infertility
38
36
40
40
40
Inflammatory Bowel Disease
58
64
70
70
69
Influenza
57
113
164
164
199
Injury (total) Accidents/Adverse Effects
349
361
353
352
349
Injury - Childhood Injuries
24
25
26
27
26
Injury - Trauma, (Head and Spine)
234
243
241
239
237
Injury - Traumatic brain injury
74
80
87
86
86
Injury - Unintentional Childhood Injury
21
20
22
22
22
Interstitial Cystitis
20
24
26
26
26
IT Computing R&D
N/A
492
509
501
491
Kidney Disease
393
388
427
424
423
Lead Poisoning
14
14
15
15
15
Liver Cancer
N/A
N/A
82
82
81
Liver Disease
388
403
454
453
450
Lung
980
1,000
1,025
1,027
1,029
Lung Cancer
296
297
289
288
285
Lupus
96
87
89
88
87
Lyme Disease
30
28
27
27
27
Lymphoma
157
166
177
176
174
Macular Degeneration
53
59
58
58
57
Malaria
72
89
104
104
107
Malaria Vaccine
23
30
44
44
48
Mental Health
1,762
1,818
1,848
1,835
1,819
Mental Retardation
190
190
192
192
191
Mind and Body
146
157
152
151
150
Minority Health
2,091
2,288
2,404
2,397
2,386
Mucopolysaccharidoses (MPS)
9
10
10
10
10
Multiple Sclerosis
99
101
110
109
108
Muscular Dystrophy
39
39
40
39
39
Myasthenia Gravis
5
4
5
5
5
Myotonic Dystrophy
N/A
6
6
6
6
Nanotechnology
N/A
106
165
172
170
Neurodegenerative
1,129
1,128
1,215
1,208
1,196
Neurofibromatosis
19
13
17
17
17
Neuropathy
N/A
51
51
51
51
Neurosciences
4,711
4,911
4,902
4,875
4,839
Nutrition
1,035
1,035
1,072
1,072
1,068
Obesity
379
422
519
519
519
Organ Transplantation
314
328
358
361
360
Orphan Drug
1,138
1,179
1,228
1,205
1,185
Osteogenesis Imperfecta
9
8
9
8
8
Osteoporosis
190
192
191
189
188
Otitis Media
15
16
15
15
15
Ovarian Cancer
119
112
106
106
105
Paget's Disease
5
6
6
6
6
Pain Conditions, Chronic
199
223
229
227
223
Parkinson's Disease
230
224
225
223
222
Pediatric
3,066
3,132
3,210
3,209
3,200
Pediatric AIDS
318
280
279
274
272
Pediatric Research Initiative
164
148
145
147
147
Pelvic Inflammatory Disease
5
4
4
4
4
Perinatal - Birth, Preterm (LBW)
407
393
394
395
395
Perinatal - Neonatal Respiratory Distress Syndrome
9
11
10
10
10
Perinatal Period - Conditions Originating in the Perinatal Period
430
428
429
429
425
Pick's Disease
N/A
1
1
1
1
Pneumonia
N/A
174
154
154
150
Pneumonia & Influenza
184
287
317
317
348
Polycystic Kidney Disease
37
34
25
25
25
Prevention
6,546
7,185
7,100
7,201
7,117
Prostate Cancer
379
378
373
376
373
Psoriasis
5
6
6
6
6
Regenerative Medicine
571
585
591
590
588
Rehabilitation
291
301
325
325
322
Rett's Syndrome
5
6
6
6
6
Reye's Syndrome
1
1
1
1
1
Rural Health
169
178
199
198
197
Schizophrenia
335
343
353
353
352
Scleroderma
13
11
11
10
10
Septicemia
30
35
42
42
41
Sexually Transmitted Diseases/Herpes
220
237
252
251
248
Sickle Cell Disease
95
90
91
91
92
Sleep Disorders
197
196
189
188
187
Smallpox
99
324
187
129
126
Smoking and Health
532
537
533
529
526
Spina Bifida
17
13
10
10
10
Spinal Cord Injury
89
89
89
88
87
Spinal Muscular Atrophy
13
14
15
15
15
Stem Cell Research
517
553
609
609
608
Stem Cell Research -- Human Embryonic
20
24
40
38
39
Stem Cell Research -- Non-Human Embryonic
113
89
97
97
96
Stem Cell Research -- Human Non-Embryonic
191
203
199
200
200
Stem Cell Research -- Non- Human Non-Embryonic
192
236
273
274
273
Stroke
330
313
342
340
338
Substance Abuse
1,462
1,496
1,508
1,495
1,482
Sudden Infant Death Syndrome
69
81
84
84
85
Suicide
31
33
34
34
34
Teenage Pregnancy
32
30
26
26
26
Temporomandibular Joint Disorder (TMJ)
16
17
20
19
19
Tobacco
531
536
531
527
524
Topical Microbicides
58
66
66
75
74
Tourette Syndrome
17
16
13
13
13
Transmissible Spongiform Encephalopathy (TSE)
31
33
37
37
37
Transplantation
504
530
545
549
548
Tuberculosis
122
137
158
158
158
Tuberculosis Vaccine
13
18
26
26
26
Tuberous Sclerosis
8
10
9
9
9
Urologic Diseases
551
595
576
575
569
Uterine Cancer
34
35
39
39
38
Vaccine Related
1,066
1,610
1,450
1,561
1,525
Vaccine Related (AIDS)
405
452
511
602
621
Vector-Borne Diseases
296
419
447
447
443
Violence Against Women
21
20
22
22
22
Violence Research
111
122
121
120
119
West Nile Virus
37
43
43
43
42
Women's Health
3,497
3,478
3,551
3,514
3,489
Youth Violence
N/A
N/A
69
68
68
           
1/ Includes research on HIV/AIDS, its associated opportunistic infections, malignancies, & clinical manifestations as well as basic science that also benefits a wide spectrum of non-AIDS disease research.

N/A = Data not available.

The FAIR Foundation: The above footnote was added by the NIH in an attempt to justify the exorbitant AIDS funding. We believe credit should go to AIDS researchers whose efforts have, by chance, been found to help patients with other diseases; however, we believe it is inappropriate for the NIH to expect non-AIDS patients to accept the gross disparities in funding because of the attitude, "AIDS research may help find a cure for your disease some day." All non-AIDS diseases represent patients who want the NIH studying their diseases in a fair and equitable manner, no more and no less.

2/ It should be noted that in the 2006 and 2007 columns, minority AIDS has been either deleted or moved away from directly under the HIV/AIDS line by the NIH. With it directly under the HIV/AIDS line, allocation of AIDS funding would be more thoroughly reported by the NIH.

Original NIH Table is at http://www.nih.gov/news/fundingresearchareas.htm#1

 

Home | The Facts | $Your Disease$ | Quiz | Newsletter | In The News | Speeches
Join FAIR | FAIR Concept | Coma Life| Donate Please | Links | Contact FAIR | Privacy Policy

Copyright © 2008 The FAIR Foundation. All rights reserved
 Webmaster     
. . . .
. . . . . . .    . . . . . . . .   . . . .    .   .